Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,484.80
(
-0.99%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
106.93
(
0.00%
)
Bitcoin
70,627.95
(
0.16%
)
News Focus
News Focus
Post# of 19309
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122806
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: shears post# 3549

Tuesday, 05/15/2007 12:41:07 PM

Tuesday, May 15, 2007 12:41:07 PM

Post# of 19309
>Is it possible that Atryn could receive FDA approval for DIC/sepsis concurrent with HD or earlier?<

That’s not possible because the DIC program will not even have started phase-3 when the BLA for the HD indication is being reviewed by the FDA.

>What if the Leo DIC studies are highly compelling?<

Approval for HD could allow for some off-label use of Atryn in DIC if the phase-2 data are extremely compelling.

>What else is there besides Xigris?<

Basically nothing. Regards, Dew

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today